Terms: = Pancreatic cancer AND SDHD, PGL1, 6392, ENSG00000204370, PGL, SDH4, CBT1, O14521 AND Diagnosis
11 results:
1. Visual analytics identifies key miRNAs for differentiating peripancreatic paraganglioma and pancreatic neuroendocrine tumors.
Enguita JM; Díaz I; García D; Cubiella T; Chiara MD; Valdés N
Front Endocrinol (Lausanne); 2023; 14():1162725. PubMed ID: 37383401
[TBL] [Abstract] [Full Text] [Related]
2. Peripancreatic paraganglioma: Lesson from a round table.
Petrelli F; Fratini G; Sbrozzi-Vanni A; Giusti A; Manta R; Vignali C; Nesi G; Amorosi A; Cavazzana A; Arganini M; Ambrosio MR
World J Gastroenterol; 2022 Jun; 28(21):2396-2402. PubMed ID: 35800185
[TBL] [Abstract] [Full Text] [Related]
3. Approach to pheochromocytoma and paraganglioma in children and adolescents: A retrospective clinical study from a tertiary care center.
Ardicli B; User IR; Ciftci AÖ; Akyuz C; Kutluk MT; Gonc N; Ozon ZA; Alikasifoglu A; Oguz B; Haliloğlu M; Orhan D; Tanyel FC; Karnak I; Ekinci S
J Pediatr Urol; 2021 Jun; 17(3):400.e1-400.e7. PubMed ID: 33593626
[TBL] [Abstract] [Full Text] [Related]
4. An autopsy case of granulocyte colony-stimulating factor-producing pancreatic adenosquamous carcinoma.
Inomata N; Masuda A; Itani T; Hayashi M; Shimada Y; Adachi K; Hashimoto K; Tanaka Y; Tanaka A; Kobayashi T; Sakai A; Shiomi H; Kodama Y
Clin J Gastroenterol; 2020 Jun; 13(3):448-454. PubMed ID: 31734879
[TBL] [Abstract] [Full Text] [Related]
5. 18F-FDOPA PET/CT of Nonfunctioning Paraganglioma of the Gastroepiploic Pedicle.
Leroy Freschini B; Addeo P; Averous G; Goichot B; Bachellier P; Imperiale A
Clin Nucl Med; 2018 Sep; 43(9):e326-e328. PubMed ID: 30004936
[TBL] [Abstract] [Full Text] [Related]
6. [Succinate dehydrogenase (SDH)-deficient renal cell carcinoma].
Agaimy A
Pathologe; 2016 Mar; 37(2):144-52. PubMed ID: 26979428
[TBL] [Abstract] [Full Text] [Related]
7. Comparison of the utility of Cocaine- and Amphetamine-Regulated Transcript (CART), chromogranin A, and chromogranin B in neuroendocrine tumor diagnosis and assessment of disease progression.
Ramachandran R; Bech P; Murphy KG; Caplin ME; Patel M; Vohra S; Khan MS; Dhillo WS; Sharma R; Palazzo FF; Win Z; Tan T; Khoo B; Meeran K; Frilling A; Ghatei MA; Bloom SR; Martin NM
J Clin Endocrinol Metab; 2015 Apr; 100(4):1520-8. PubMed ID: 25664601
[TBL] [Abstract] [Full Text] [Related]
8. [Genetics of pheochromocytoma].
Bausch B; Malinoc A; Maruschke L; Offergeld C; Gläsker S; Rischke HC; Brauckhoff M; Boedeker CC; Neumann HP
Chirurg; 2012 Jun; 83(6):511-8. PubMed ID: 22481546
[TBL] [Abstract] [Full Text] [Related]
9. Long-term outcomes, branch-specific expressivity, and disease-related mortality in von Hippel-Lindau type 2A.
Nielsen SM; Rubinstein WS; Thull DL; Armstrong MJ; Feingold E; Yip L; Tisherman SA; Carty SE
Fam Cancer; 2011 Dec; 10(4):701-7. PubMed ID: 21713522
[TBL] [Abstract] [Full Text] [Related]
10. Expression of somatostatin receptors, dopamine D₂ receptors, noradrenaline transporters, and vesicular monoamine transporters in 52 pheochromocytomas and paragangliomas.
Saveanu A; Muresan M; De Micco C; Taieb D; Germanetti AL; Sebag F; Henry JF; Brunaud L; Enjalbert A; Weryha G; Barlier A
Endocr Relat Cancer; 2011 Apr; 18(2):287-300. PubMed ID: 21335363
[TBL] [Abstract] [Full Text] [Related]
11. Familial pheochromocytoma.
Erlic Z; Neumann HP
Hormones (Athens); 2009; 8(1):29-38. PubMed ID: 19269919
[TBL] [Abstract] [Full Text] [Related]
